145 related articles for article (PubMed ID: 32020607)
1. Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer.
Shao M; Ma H; Wan X; Liu Y
J Cell Physiol; 2020 Oct; 235(10):6574-6581. PubMed ID: 32020607
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic study of early breast cancer (EBC) based on DNA methylation and gene integration analysis.
Zhang W; Wang H; Qi Y; Li S; Geng C
Sci Rep; 2022 Feb; 12(1):1989. PubMed ID: 35132081
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
Tuersong T; Li L; Abulaiti Z; Feng S
Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
[TBL] [Abstract][Full Text] [Related]
5. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of DRAIC and TP53TG1 in breast cancer luminal subtypes through the construction of lncRNAs regulatory model.
Motalebzadeh J; Eskandari E
Breast Cancer; 2022 Nov; 29(6):1050-1066. PubMed ID: 35871431
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of an epigenetically regulated long noncoding RNA model for breast cancer metabolism and prognosis.
Song Y; Shen S; Sun Q
BMC Med Genomics; 2022 May; 15(1):105. PubMed ID: 35525949
[TBL] [Abstract][Full Text] [Related]
8. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
9. A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
He Y; Li X; Meng Y; Fu S; Cui Y; Shi Y; Du H
J Cell Biochem; 2019 Oct; 120(10):16692-16702. PubMed ID: 31095790
[TBL] [Abstract][Full Text] [Related]
10. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.
Heilmann K; Toth R; Bossmann C; Klimo K; Plass C; Gerhauser C
Oncogene; 2017 Nov; 36(46):6446-6461. PubMed ID: 28759043
[TBL] [Abstract][Full Text] [Related]
12. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs as prognostic markers in human breast cancer.
Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY
Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882
[TBL] [Abstract][Full Text] [Related]
14. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S; Saidijam M; Malih N
Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
[TBL] [Abstract][Full Text] [Related]
16. Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma.
Ji J; Zhao L; Zhao X; Li Q; An Y; Li L; Li D
Int J Mol Med; 2020 Jul; 46(1):224-238. PubMed ID: 32319552
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.
Diaz-Lagares A; Crujeiras AB; Lopez-Serra P; Soler M; Setien F; Goyal A; Sandoval J; Hashimoto Y; Martinez-Cardús A; Gomez A; Heyn H; Moutinho C; Espada J; Vidal A; Paúles M; Galán M; Sala N; Akiyama Y; Martínez-Iniesta M; Farré L; Villanueva A; Gross M; Diederichs S; Guil S; Esteller M
Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7535-E7544. PubMed ID: 27821766
[TBL] [Abstract][Full Text] [Related]
18. Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
Ma X; Yu L; Wang P; Yang X
Comput Biol Chem; 2017 Aug; 69():164-170. PubMed ID: 28501295
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival.
Guo W; Wang Q; Zhan Y; Chen X; Yu Q; Zhang J; Wang Y; Xu XJ; Zhu L
Sci Rep; 2016 Jun; 6():27931. PubMed ID: 27338266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
